Heranba Industries Adjusts Valuation Grade Amidst Competitive Agrochemical Landscape
Heranba Industries, a small-cap player in the pesticides and agrochemicals sector, has adjusted its valuation metrics, showcasing a high price-to-earnings ratio and a notable price-to-book value. Despite a low return on equity, the company has demonstrated positive stock performance relative to the broader market, highlighting its unique position among peers.
Heranba Industries, a small-cap player in the pesticides and agrochemicals sector, has recently undergone a valuation adjustment, reflecting its current market standing. The company's price-to-earnings ratio stands at 392.29, indicating a significant premium compared to its peers. Additionally, its price-to-book value is recorded at 1.43, while the enterprise value to EBITDA ratio is 15.27, suggesting a robust valuation framework.Despite a dividend yield of 0.40% and a return on capital employed (ROCE) of 3.64%, Heranba's return on equity (ROE) is relatively low at 0.36%. In terms of market performance, the stock has shown a return of 3.02% over the past week and 15.52% over the last month, contrasting with a slight decline in the broader Sensex index.
When compared to its peers, Heranba Industries presents a unique position. While some competitors like Bhagiradha Chemicals and Bharat Rasayan are categorized differently in terms of valuation, Heranba's metrics highlight its distinct market approach. The company's performance indicators suggest a complex landscape within the pesticides and agrochemicals industry, emphasizing the varied financial health and market strategies of its competitors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
